Patent ID: 11945798
Assignee: JANSSEN BIOTECH, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC A  C | IPC C

Claim 17:
18. The compound of claim 1, or a pharmaceutically acceptable salt thereof, wherein R2A is independently selected from the group consisting of H;
halogen;
OH;
C1-6 alkyl optionally substituted by one or more substituents selected from the group consisting of OH, NH2, halogen, C3-6 cycloalkyl, —NHC1-6 alkyl, —NHC1-6 hydroxyalkyl, —NHC1-6 haloalkyl, —NHC3-6 cycloalkyl, —N(C1-6alkyl)2, —NHC(O)C1-6 alkyl, 3-7 membered heterocyclyl, imidazolyl, and pyrazolyl;
—NHC1-6 alkyl optionally substituted by one or more substituents selected from the group consisting of OH, halogen, —N(C1-6alkyl)2, and 3-7 membered heterocyclyl optionally substituted by halogen or —N(C1-6alkyl)2;
—N(C1-6 alkyl)2;
—NH-4-7 membered heterocyclyl optionally substituted by C1-6 alkyl; and
4-7 membered heterocyclyl.